PHARMACYTE BIOTECH, INC. Federal Income Tax Expense (Benefit), Continuing Operations
PHARMACYTE BIOTECH, INC. (PMCB) reported Federal Income Tax Expense (Benefit), Continuing Operations of $70.09 thousand for the 12-month period ending 2024-04-30, per its 10-K filed 2024-08-13.
Discontinued › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2024-08-13
- PHARMACYTE BIOTECH, INC. federal income tax expense (benefit), continuing operations for fiscal 2024 was $70.09K.
- PHARMACYTE BIOTECH, INC. federal income tax expense (benefit), continuing operations for fiscal 2023 was -$906.36K.
- PHARMACYTE BIOTECH, INC. federal income tax expense (benefit), continuing operations for fiscal 2022 was -$890.22K.
- PHARMACYTE BIOTECH, INC. federal income tax expense (benefit), continuing operations for fiscal 2021 was -$745.76K.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month | Federal Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|
| 2024-04-30 | $70.09K 10-K · filed 2024-08-13 | |
| 2023-04-30 | -$906.36K 10-K · filed 2024-08-13 | |
| 2022-04-30 | -$890.22K 10-K · filed 2023-07-31 | |
| 2021-04-30 | -$745.76K 10-K · filed 2022-07-28 | |
| 2020-04-30 | -$803.65K 10-K · filed 2021-08-10 | |
| 2019-04-30 | -$854.12K 10-K · filed 2020-08-13 | |
| 2018-04-30 | -$2.32M 10-K · filed 2019-08-13 | |
| 2017-04-30 | -$1.51M 10-K · filed 2018-07-20 | |
| 2016-04-30 | -$2.06M 10-K · filed 2017-07-27 | |
| 2015-04-30 | -$3.38M 10-K · filed 2016-07-29 | -$3.69M 10-K · filed 2015-07-29 |
| 2014-04-30 | -$8.87M 10-K · filed 2016-07-29 | |
| 2013-04-30 | -$543.36K 10-K/A · filed 2016-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |